Big news from the traditional finance world: Britain and the United States just locked in a zero-tariff agreement specifically targeting pharmaceuticals. This marks a significant shift in trade dynamics between these two economic powerhouses.

The deal eliminates tariff barriers on pharmaceutical products moving across the Atlantic, which could reshape supply chains and pricing structures in the healthcare sector. For those watching macro trends, this kind of policy coordination between major economies often signals broader shifts in trade relationships.

While this is purely a pharma play, the ripple effects on market confidence and capital flows shouldn't be ignored. Trade agreements like this tend to influence risk appetite across asset classes, including digital assets. Worth keeping on your radar as these developments unfold.